Next Article in Journal
Murine Bone Marrow Niches from Hematopoietic Stem Cells to B Cells
Next Article in Special Issue
Effects of Er:YAG and Diode Laser Irradiation on Dental Pulp Cells and Tissues
Previous Article in Journal
Fusarium graminearum ATP-Binding Cassette Transporter Gene FgABCC9 Is Required for Its Transportation of Salicylic Acid, Fungicide Resistance, Mycelial Growth and Pathogenicity towards Wheat
Previous Article in Special Issue
Reevaluation of Pluripotent Cytokine TGF-β3 in Immunity
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2018, 19(8), 2352;

TGF-Beta Signaling in Bone with Chronic Kidney Disease

Department of Health Sciences, Oita University of Nursing and Health Sciences, Oita 870-1163, Japan
Division of Nephrology and Metabolism, Tokai University School of Medicine, Kanagawa 259-119, Japan
Author to whom correspondence should be addressed.
Received: 9 July 2018 / Revised: 30 July 2018 / Accepted: 8 August 2018 / Published: 10 August 2018
(This article belongs to the Special Issue TGF-Beta Super Family Signaling)
Full-Text   |   PDF [553 KB, uploaded 10 August 2018]   |  


Transforming growth factor (TGF)-β signaling is not only important in skeletal development, but also essential in bone remodeling in adult bone. The bone remodeling process involves integrated cell activities induced by multiple stimuli to balance bone resorption and bone formation. TGF-β plays a role in bone remodeling by coordinating cell activities to maintain bone homeostasis. However, mineral metabolism disturbance in chronic kidney disease (CKD) results in abnormal bone remodeling, which leads to ectopic calcification in CKD. High circulating levels of humoral factors such as parathyroid hormone, fibroblast growth factor 23, and Wnt inhibitors modulate bone remodeling in CKD. Several reports have revealed that TGF-β is involved in the production and functions of these factors in bone. TGF-β may act as a factor that mediates abnormal bone remodeling in CKD. View Full-Text
Keywords: bone remodeling; mineral metabolism disturbance; chronic kidney disease; humoral factors bone remodeling; mineral metabolism disturbance; chronic kidney disease; humoral factors

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Iwasaki, Y.; Yamato, H.; Fukagawa, M. TGF-Beta Signaling in Bone with Chronic Kidney Disease. Int. J. Mol. Sci. 2018, 19, 2352.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top